In the last 12 months, insiders at Armata Pharmaceuticals, Inc. ($ARMP) filed 41 transactions with the SEC: 0 open-market purchases totaling $0 and 0 sales totaling $0. Net insider sentiment: neutral.
Armata Pharmaceuticals, Inc. operates in the Biological products, (no disgnostic substances) industry (Life sciences sector).
Most Active Insiders
- Birx Deborah (Chief Executive Officer) — 8 transactions totaling $156,060
- Kyme Pierre (Chief Business Officer) — 4 transactions totaling $12,859
- Odysseas Kostas D (Director) — 4 transactions totaling $0
- Kramer Robin (Director) — 4 transactions totaling $0
- Haimovitz Jules (Director) — 4 transactions totaling $0
View all SEC Filings for Armata Pharmaceuticals, Inc. (ARMP).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 14, 2026 | Birx Deborah | Chief Executive Officer | F | Common Stock | 4919 | $10.54 | 212,458.0000 | 36,226,285 | 2.26% | 0.01% |
| March 14, 2026 | Kyme Pierre | Chief Business Officer | F | Common Stock | 1030 | $10.54 | 9,461.0000 | 36,226,285 | 9.82% | 0.00% |
| March 9, 2026 | Kramer Robin | Director | A | Stock Options (Right to Buy) | 25640 | $0.00 | 25,640.0000 | 36,226,285 | 9999.99% | 0.07% |
| March 9, 2026 | PATTI JOSEPH M | Director | A | Stock Options (Right to Buy) | 25640 | $0.00 | 25,640.0000 | 36,226,285 | 9999.99% | 0.07% |
| March 9, 2026 | Kyme Pierre | Chief Business Officer | A | Stock Options (Right to Buy) | 183142 | $0.00 | 183,142.0000 | 36,226,285 | 9999.99% | 0.51% |
| March 9, 2026 | House David Duane | SVP, Finance, and PFO | A | Stock Options (Right to Buy) | 109885 | $0.00 | 109,885.0000 | 36,226,285 | 9999.99% | 0.30% |
| March 9, 2026 | Haimovitz Jules | Director | A | Stock Options (Right to Buy) | 25640 | $0.00 | 25,640.0000 | 36,226,285 | 9999.99% | 0.07% |
| March 9, 2026 | Schlesinger Sarah J. | Director | A | Stock Options (Right to Buy) | 25640 | $0.00 | 25,640.0000 | 36,226,285 | 9999.99% | 0.07% |
| March 9, 2026 | Birx Deborah | Chief Executive Officer | A | Stock Options (Right to Buy) | 421226 | $0.00 | 421,226.0000 | 36,226,285 | 9999.99% | 1.16% |
| March 9, 2026 | Odysseas Kostas D | Director | A | Stock Options (Right to Buy) | 25640 | $0.00 | 25,640.0000 | 36,226,285 | 9999.99% | 0.07% |
| March 9, 2026 | Peterson Todd C. | Director | A | Stock Options (Right to Buy) | 25640 | $0.00 | 25,640.0000 | 36,226,285 | 9999.99% | 0.07% |
| July 10, 2025 | Birx Deborah | Chief Executive Officer | F | Common Stock | 13637 | $2.27 | 217,377.0000 | 36,193,479 | 5.90% | 0.04% |
| March 14, 2025 | Kyme Pierre | Chief Business Officer | F | Common Stock | 1027 | $1.95 | 10,491.0000 | 59,059,971 | 8.92% | 0.00% |
| July 10, 2024 | Birx Deborah | Chief Executive Officer | F | Common Stock | 22925 | $2.68 | 237,075.0000 | 58,246,626 | 8.82% | 0.04% |
| March 14, 2025 | Birx Deborah | Chief Executive Officer | F | Common Stock | 6061 | $1.95 | 231,014.0000 | 59,059,971 | 2.56% | 0.01% |
| Feb. 5, 2025 | Birx Deborah | Chief Executive Officer | A | Stock Options (Right to Buy) | 240000 | $0.00 | 240,000.0000 | 59,059,971 | 9999.99% | 0.41% |
| Feb. 5, 2025 | Odysseas Kostas D | Director | A | Stock Options (Right to Buy) | 54343 | $0.00 | 54,343.0000 | 59,059,971 | 9999.99% | 0.09% |
| Feb. 5, 2025 | Schlesinger Sarah J. | Director | A | Stock Options (Right to Buy) | 54343 | $0.00 | 54,343.0000 | 59,059,971 | 9999.99% | 0.09% |
| Feb. 5, 2025 | Peterson Todd C. | Director | A | Stock Options (Right to Buy) | 54343 | $0.00 | 54,343.0000 | 59,059,971 | 9999.99% | 0.09% |
| Feb. 5, 2025 | PATTI JOSEPH M | Director | A | Stock Options (Right to Buy) | 54343 | $0.00 | 54,343.0000 | 59,059,971 | 9999.99% | 0.09% |
| Feb. 5, 2025 | Kyme Pierre | Chief Business Officer | A | Stock Options (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 59,059,971 | 9999.99% | 0.17% |
| Feb. 5, 2025 | Kramer Robin | Director | A | Stock Options (Right to Buy) | 54343 | $0.00 | 54,343.0000 | 59,059,971 | 9999.99% | 0.09% |
| Feb. 5, 2025 | House David Duane | SVP, Finance, and PFO | A | Stock Options (Right to Buy) | 25000 | $0.00 | 25,000.0000 | 59,059,971 | 9999.99% | 0.04% |
| Feb. 5, 2025 | Haimovitz Jules | Director | A | Stock Options (Right to Buy) | 54343 | $0.00 | 54,343.0000 | 59,059,971 | 9999.99% | 0.09% |
| Oct. 2, 2024 | House David Duane | SVP, Finance, and PFO | A | Stock Options (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 36,180,124 | 9999.99% | 0.21% |
| March 14, 2024 | Schlesinger Sarah J. | Director | A | Stock Options (Right to Buy) | 54343 | $0.00 | 94,009.0000 | 36,075,555 | 137.00% | 0.15% |
| March 14, 2024 | Haimovitz Jules | Director | A | Stock Options (Right to Buy) | 39666 | $0.00 | 39,666.0000 | 36,075,555 | 9999.99% | 0.11% |
| March 14, 2024 | Haimovitz Jules | Director | A | Stock Options (Right to Buy) | 54343 | $0.00 | 94,009.0000 | 36,075,555 | 137.00% | 0.15% |
| March 14, 2024 | Odysseas Kostas D | Director | A | Stock Options (Right to Buy) | 39666 | $0.00 | 39,666.0000 | 36,075,555 | 9999.99% | 0.11% |
| March 14, 2024 | Odysseas Kostas D | Director | A | Stock Options (Right to Buy) | 54343 | $0.00 | 94,009.0000 | 36,075,555 | 137.00% | 0.15% |
| March 14, 2024 | Birx Deborah | Chief Executive Officer | A | Common Stock | 60000 | $0.00 | 260,000.0000 | 36,075,555 | 30.00% | 0.17% |
| March 14, 2024 | Birx Deborah | Chief Executive Officer | A | Stock Options (Right to Buy) | 240000 | $0.00 | 240,000.0000 | 36,075,555 | 9999.99% | 0.67% |
| March 14, 2024 | Schlesinger Sarah J. | Director | A | Stock Options (Right to Buy) | 39666 | $0.00 | 39,666.0000 | 36,075,555 | 9999.99% | 0.11% |
| March 14, 2024 | Rychlik Richard | Corporate Controller and PFO | A | Stock Options (Right to Buy) | 40000 | $0.00 | 40,000.0000 | 36,075,555 | 9999.99% | 0.11% |
| March 14, 2024 | Rychlik Richard | Corporate Controller and PFO | A | Common Stock | 10000 | $0.00 | 10,000.0000 | 36,075,555 | 9999.99% | 0.03% |
| March 14, 2024 | Peterson Todd C. | Director | A | Stock Options (Right to Buy) | 54343 | $0.00 | 94,009.0000 | 36,075,555 | 137.00% | 0.15% |
| March 14, 2024 | Peterson Todd C. | Director | A | Stock Options (Right to Buy) | 39666 | $0.00 | 39,666.0000 | 36,075,555 | 9999.99% | 0.11% |
| March 14, 2024 | Kramer Robin | Director | A | Stock Options (Right to Buy) | 54343 | $0.00 | 94,009.0000 | 36,075,555 | 137.00% | 0.15% |
| March 14, 2024 | Kramer Robin | Director | A | Stock Options (Right to Buy) | 39666 | $0.00 | 39,666.0000 | 36,075,555 | 9999.99% | 0.11% |
| March 14, 2024 | PATTI JOSEPH M | Director | A | Stock Options (Right to Buy) | 54343 | $0.00 | 94,009.0000 | 36,075,555 | 137.00% | 0.15% |
| March 14, 2024 | PATTI JOSEPH M | Director | A | Stock Options (Right to Buy) | 39666 | $0.00 | 39,666.0000 | 36,075,555 | 9999.99% | 0.11% |